Selecting the right sites with the right patient populations is arguably one of the most important aspects of every study, yet many companies do not leverage effective decision support data and site feasibility tools to improve and accelerate the process.

ePharmaSolutions has developed a suite of services and technical solutions that take the guesswork out of site selection and help accelerate and improve site response rates. ePharmaSolutions’ Global Site Feasibility Department tracks the experience and background of more than 200,000 experienced Investigators in 120 countries detailing the number of studies conducted in each indication, their practice setting, patient populations, regulatory information, and other important data points. ePharmaSolutions’ proprietary Site Feasibility Application allows study teams to quickly develop an online site recruitment and feasibility campaign that provides quantitative data and protocol-specific feasibility scores to aid the decision-making process.

Recently, ePharmaSolutions has integrated a robust Electronic Medical Record (EMR) dataset of more than 80 million patients into its U.S. Investigator database. This HIPAA compliant solution tracks the patient populations on more than 350,000 practicing physicians in more than 100,000 institutions to pinpoint the number of disease-specific patients each Investigative site treats per month. This allows our clients to find sites with direct trial experience in the indication of choice and profile that physician’s patient population by the number of unique diagnoses, procedures, and prescriptions written in a given time period. Further, the EMR data tracks and profiles the patient populations at potential referral physicians’ facilities to evaluate the benefit a referral program might have at each site.

• Country, protocol and site feasibility knowledge
• Online feasibility survey development; from simple to complex intelligent branching with sophisticated weighting algorithms to score sites
• Reminder services to ensure timely completion of surveys
• A proprietary Investigator database with over 200,000 Investigators in 120 countries
• Electronic CDA capability reduces cycle time compared to paper based process
• Real time reporting
• EMR claims data on 80 million longitudinal patient lives and 350,000 physicians

The Process
ePharmaSolutions' Global Site Feasibility Department has provided global protocol and site feasibility support in various indications on every continent for studies ranging from 5 to 2,500 sites.  

Our team of clinical professionals will guide you through the survey development process and manage the technological and administrative aspects of the site selection process. Drawing on our extensive experience, the team provides expert guidance in developing a survey that is thorough enough to meet the scientific and operational needs of the client while ensuring that the survey remains user friendly for sites. An appropriate communication plan will be developed in consultation with the client to optimize response rate. A team of trained individuals is available to implement the communication plan if needed.

A Site Identification and Feasibility Tracking report (SIFT) is customized during the planning stages of the project. This report contains communication metrics and survey results that can be viewed online for rapid decision making or exported to Microsoft Excel for further analysis. ePharmaSolutions’ exclusive access to 80 million longitudinal patient health records can be leveraged to validate access to patients at each site. This data can be integrated directly into the SIFT report, providing a multi-dimensional view of a site's ability to perform on a given protocol.

For more information or to contact ePharmaSolutions click here.